China International Capital Corporation Limited
SEHK-3908
Company Overview
China International Capital Corporation Limited provides financial services in Mainland China and internationally. The company operates through six segments: Investment Banking; Equities; Fixed Income, Commodities, and Currencies (FICC); Asset Management; Private Equity; and Wealth Management. The Investment Banking segment provides investment banking services, including equity financing, debt, and structured financing and financial advisory services. The Equity segment offers investment research, sales, trading, and products and cross-border services, including institutional trading and capital services, such as primary brokerage, over-the-counter derivatives, capital introduction, and market-making transactions. The FICC segment provides fixed-income products, such as interest rate, credit, and structured products, as well as on overseas exchange and commodities. The Asset Management segment engages in the social security and annuity investment management, institutional entrusted investment management, overseas asset management, retail and mutual fund businesses, etc. The Private Equity segment provides corporate equity funds, fund of funds, dollar funds, real estate funds, infrastructure funds, etc. The Wealth Management segment offers wealth transactional, capital, and product configuration services. The company serves domestic and overseas investors, and corporations and institutional clients, as well as retail clients, families, and corporate clients. China International Capital Corporation Limited was incorporated in 1995 and is headquartered in Beijing, the People's Republic of China.
Name
China International Capital Corporation Limited
CEO
Mr. Liang Chen
Website
www.cicc.com
Sector
Capital Markets
Year Founded
1995
Profile
Market Cap
HK$106.92B
EV
—
Shares Out
4,827.26M
Revenue
CN¥20.69B
Employees
15,081
Margins
Gross
92.06%
EBITDA
—
Operating
—
Pre-Tax
24.89%
Net
23.31%
FCF
85.56%
Returns (5Yr Avg)
ROA
1.36%
ROTA
10.11%
ROE
9.94%
ROCE
—
ROIC
3.26%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
HK$12.11
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
CN¥63.07B
Net Debt
-CN¥138.06B
Debt/Equity
2.63
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
-13.83%
Rev 5Yr
8.5%
Rev 10Yr
18.2%
Dil EPS 3Yr
-23.28%
Dil EPS 5Yr
-0.36%
Dil EPS 10Yr
10.1%
Rev Fwd 2Yr
-14.78%
EBITDA Fwd 2Yr
-10.87%
EPS Fwd 2Yr
4.83%
EPS LT Growth Est
13.47%
Dividends
Yield
—
Payout
20.88%
DPS
CN¥0.18
DPS Growth 3Yr
14.47%
DPS Growth 5Yr
11.03%
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
17.84%